Herein, our data proved that plasma exosomal LINC00265, LINC00467, UCA1, and SNHG1 might act as promising cell-free biomarkers for diagnosis and treatment monitoring of AML. This evidence concerns the gene SNHG1 and acute myeloid leukemia.